Becton Dickinson & Co (BDX): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Becton Dickinson ( BDX) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day down 0.6%. By the end of trading, Becton Dickinson rose 82 cents (1.1%) to $75.45 on average volume. Throughout the day, 1.2 million shares of Becton Dickinson exchanged hands as compared to its average daily volume of 983,100 shares. The stock ranged in a price between $74.65-$75.55 after having opened the day at $74.73 as compared to the previous trading day's close of $74.63. Other companies within the Health Services industry that increased today were: Electromed ( ELMD), up 14.5%, ImmunoCellular Therapeutics ( IMUC), up 9.2%, Hooper Holmes ( HH), up 7.2%, and Healthways ( HWAY), up 7.1%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. Becton Dickinson has a market cap of $14.94 billion and is part of the health care sector. The company has a P/E ratio of 14.1, below the S&P 500 P/E ratio of 17.7. Shares are up 0.2% year to date as of the close of trading on Wednesday. Currently there are four analysts that rate Becton Dickinson a buy, five analysts rate it a sell, and eight rate it a hold.

TheStreet Ratings rates Becton Dickinson as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, CombiMatrix Corporation ( CBMX), down 35.1%, Cynosure ( CYNO), down 12.5%, Thermogenesis Corporation ( KOOL), down 10.5%, and Alliance HealthCare Services ( AIQ), down 8.7%, were all laggards within the health services industry with HCA Holdings ( HCA) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

FREE for a limited time only: Get TheStreet Ratings #1 Stock Report NOW!.